# Frier Levitt

> At Frier Levitt, we provide legal guidance that empowers healthcare, life sciences and pharmacy clients to manage regulatory complexity and achieve success\.

Generated by Yoast SEO v28.5, this is an llms.txt file, meant for consumption by LLMs.

## Pages
- [Homepage](https://www.frierlevitt.com/)
- [Cookie Policy](https://www.frierlevitt.com/cookie-policy/)
- [About](https://www.frierlevitt.com/about-us/)
- [SMS NOTIFICATIONS](https://www.frierlevitt.com/sms-notifications/)
- [University of Michigan v\. CVS Health Corp](https://www.frierlevitt.com/university-of-michigan-v-cvs-health-corp/)

## Posts
- [Benjamin Youssef Featured in Drug Topics: Johnson \& Johnson Next Major Drugmaker to Require 340B Claims Data](https://www.frierlevitt.com/news/johnson-johnson-340b-claims-data-requirements/)
- [Johnson \& Johnson Joins the Manufacturer Claims\-Data Push: What 340B Covered Entities Need to Know](https://www.frierlevitt.com/articles/johnson-johnson-340b-claims-data-policy-covered-entities/)
- [Navigating a Board Investigation Part 1: The Anatomy of a Board Investigation \(On\-Demand Access\)](https://www.frierlevitt.com/webinars/navigating-a-board-investigation-part-1-the-anatomy-of-a-board-investigation/)
- [Alex Keoskey Presents at PAINWeek 2026](https://www.frierlevitt.com/events/alex-keoskey-painweek-2026/)
- [FDA Advisory Committee Recommends Six Peptides for 503A Compounding: What Businesses Need to Know](https://www.frierlevitt.com/news/fda-pcac-peptides-503a-compounding/)

## Attorneys
- [Marc B\. Viscuso](https://www.frierlevitt.com/attorney/marc-b-viscuso/)
- [Mariaeva Batlle](https://www.frierlevitt.com/attorney/mariaeva-batlle/)
- [Winston S\. Kirton](https://www.frierlevitt.com/attorney/winston-s-kirton/)
- [Nicole M\. DeWitt](https://www.frierlevitt.com/attorney/nicole-m-dewitt/)
- [Brandon S\. Zarsky](https://www.frierlevitt.com/attorney/brandon-s-zarsky/)

## Services
- [Home Infusion Providers](https://www.frierlevitt.com/service/pharmacy-providers/home-infusion-providers/)
- [MAC Pricing and Appeals](https://www.frierlevitt.com/service/life-sciences-and-pharmacy-litigation/mac-pricing-and-appeals/)
- [Pharmaceutical Manufacturers](https://www.frierlevitt.com/service/pharmaceutical-manufacturers/)
- [Intellectual Property Services](https://www.frierlevitt.com/service/intellectual-property-services/)
- [Peptide \& GLP\-1 Industry](https://www.frierlevitt.com/service/peptides-and-glp-1/)

## Categories
- [Results](https://www.frierlevitt.com/category/results/)
- [Resources](https://www.frierlevitt.com/category/resources/)
- [News](https://www.frierlevitt.com/category/news/)
- [Podcasts](https://www.frierlevitt.com/category/podcasts/)
- [Webinars](https://www.frierlevitt.com/category/webinars/)

## Tags
- [Pharmacy Law](https://www.frierlevitt.com/tag/pharmacylaw/)
- [Ambulatory Care Facilities](https://www.frierlevitt.com/tag/ambulatory-care-facilities/)
- [Healthcare](https://www.frierlevitt.com/tag/healthcare/)
- [Healthcare Law](https://www.frierlevitt.com/tag/healthcarelaw/)
- [Defending Pharmacies in PBM Audits](https://www.frierlevitt.com/tag/defending-pharmacies-in-pbm-audits/)

## Optional
- [Sitemap index](https://www.frierlevitt.com/sitemap_index.xml)